Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.069 | 0.7 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |